Blog
Who gets paid when I fill a $500 prescription? Following the money
One hypothetical $500 brand prescription traced through the pharmacy, benefit manager, insurer, rebate and your coinsurance, with every dollar accounted for.
You hand over your card, the pharmacist types in a brand-name drug and the screen says $150. The drug's price is $500. Somebody got $500, somebody got less, and the rest of the money moved through companies you have never seen a bill from. This walkthrough follows one fill, dollar by dollar, so you can see which party gets what and why your share can feel large next to what anyone ends up keeping.
Everything below is a made-up illustration with round numbers. It is not any company's contract, any real drug's price or a claim about how a particular insurer, pharmacy or benefit manager behaves. Real contracts differ, and most of their terms are confidential. The point is to show the structure of the money.
The cast
Five parties touch this fill.
- You, the patient, who owes cost sharing.
- The pharmacy, which buys the drug and hands it to you.
- The insurer or plan sponsor, which pays most of the bill and takes the financial risk.
- The pharmacy benefit manager, the company the plan hires to run the drug benefit: it sets up the pharmacy network, processes claims, manages the drug list and negotiates with manufacturers. what pharmacy benefit managers do and why they matter gives the background.
- The manufacturer, which makes the drug and sets its list price.
There is also a wholesaler between manufacturer and pharmacy that moves the drug in bulk. To keep the arithmetic readable, this example leaves the wholesaler's own margin inside the price the pharmacy pays.
The numbers we will use
- The drug is a brand-name drug with a list price of $500 per fill, which is also the price the plan has agreed that the pharmacy will be paid for the claim.
- The pharmacy buys the drug for $470.
- Your plan charges 30% coinsurance on this drug, and your deductible has already been met this year. If it had not, the story would start differently, as shown later.
- The manufacturer pays a rebate of $125 (25% of list) to the benefit manager because the plan places the drug on its formulary.
- The benefit manager keeps $10 of that rebate under its contract and passes $115 to the plan.
- The plan also pays the benefit manager an administrative fee of $2 per claim.
Step 1: At the counter
The pharmacy sends the claim to the benefit manager's system. In a fraction of a second the system checks that you are covered, that the drug is on the list, that no approval is needed and what the cost sharing is. It sends back the answer: the plan allows $500 for this drug; the patient owes 30%, which is $150; the plan owes the rest, $350.
You pay $150 at the register. The pharmacy collects $350 from the benefit manager or plan later, according to its contract, commonly within a couple of weeks.
At this moment, the pharmacy's books show:
| Item | Amount |
|---|---|
| Received from you | $150 |
| Owed by the plan | $350 |
| Total for the claim | $500 |
| Cost of the drug | $470 |
| Gross margin | $30 |
The $30 is before the pharmacy's own costs: the pharmacist's time, rent, staff, insurance, the vial and the label. A pharmacy's gross margin on a brand drug can be thin, and sometimes it is smaller than its cost of filling the prescription. Other drugs, especially generics, can have larger margins. The structure of the payment, not the drug alone, sets it.
Step 2: The plan's payment
The plan paid $350 at the counter. It also paid the $2 per-claim fee to the benefit manager. So far, the plan is out $352.
If that were the whole story, the plan's net cost would be $352. But the rebate is still to come.
Step 3: The rebate
A drug manufacturer and a benefit manager negotiate a drug rebate: the manufacturer pays back a share of the list price in return for favorable treatment, such as placing the drug on the plan's list or limiting competing products. The rebate is paid after the fact, usually quarterly, based on claims. It is not subtracted at the pharmacy counter in most commercial plans.
In our example the manufacturer owes $125 per fill. The benefit manager collects it, keeps $10 under its contract and passes the remaining $115 to the plan, usually in a periodic payment and not claim by claim.
Contracts differ here. Some benefit managers pass through all or most rebates. Others keep a share, or keep fees in lieu of a share. Some plans choose a contract in which they get a lower rebate share in exchange for lower fees. A plan sponsor, often an employer, can ask its benefit manager what its contract does.
Step 4: Adding it up
Now we can trace where each dollar landed, with the rebate included.
Money paid in:
- You paid $150.
- The plan paid $350 at the counter plus $2 in fees = $352.
- The plan received back $115 in rebate pass-through.
- The plan's net cost: $352 − $115 = $237.
So the money that entered the system for this fill, after the rebate pass-through, was your $150 plus the plan's net $237, which is $387.
Where $387 landed:
| Party | How it earned money | Amount |
|---|---|---|
| Pharmacy | $500 received − $470 drug cost | $30 |
| Benefit manager | $10 retained rebate + $2 fee | $12 |
| Manufacturer | $470 received from the pharmacy's purchase − $125 rebate | $345 |
| Total | $387 |
The check: $30 + $12 + $345 = $387, which equals $150 + $237. Every dollar is accounted for.
Look at two numbers in that table. The manufacturer, whose list price is $500, nets $345, which is 69% of the list price. And you paid $150 toward a drug whose real net cost to the system was $387, which is about 38.8% of it, though your plan says you owe 30%.
Two other contracts, same patient price
The patient's $150 does not depend on how the benefit manager's contract handles the rebate. Change the contract and everything except your share moves. Both variations below keep the $500 price, the $470 pharmacy cost, the 30% coinsurance and the $2 fee.
A contract where the benefit manager keeps more. Say it keeps $40 of the $125 rebate and passes $85 to the plan.
- Plan net: $352 − $85 = $267.
- Total net money: your $150 + $267 = $417.
- Landing: pharmacy $30, benefit manager $40 + $2 = $42, manufacturer $345. Check: $30 + $42 + $345 = $417.
A drug with no rebate. Say the manufacturer pays nothing on this drug, perhaps because the plan does not prefer it over a competitor.
- Plan net: $352 with nothing coming back.
- Total net money: your $150 + $352 = $502.
- Landing: pharmacy $30, benefit manager $2, manufacturer $470. Check: $30 + $2 + $470 = $502.
Across all three versions, you paid $150. The plan's net cost ranged from $237 to $352, and the manufacturer's net ranged from $345 to $470. That is the sense in which a patient's cost can be disconnected from what anyone nets: your coinsurance responds to the counter price, and the contract terms decide who keeps the rest.
Why your share looks bigger than 30%
The 30% coinsurance was applied to $500, the price at the counter, before the rebate. The rebate flows to the plan, not to you. In most plans, cost sharing is based on a price that does not reflect the rebate, because the rebate comes later and is paid to the plan sponsor as a whole.
Here is the same fill if coinsurance were applied to the price after the full $125 rebate:
- Price after rebate: $500 − $125 = $375.
- 30% of $375 = $112.50.
- Compared with the $150 you paid, the difference is $37.50 per fill.
That calculation is only for illustration. Whether any plan could or should do that is the subject of a policy debate, and arguments on each side appear in Why do I pay coinsurance on a drug price my plan gets a rebate on?.
Two variations at your end of the counter
If you had a copay instead
Suppose the plan used a flat $50 copay on this tier instead of coinsurance.
- You pay $50 at the counter.
- The plan pays $450.
- The rebate and fees are the same, so the plan's net is $450 + $2 − $115 = $337.
- Check: you $50 + plan net $337 = $387, the same total.
The total net money is unchanged; only who pays it shifts. A copay is predictable, while coinsurance moves with the price. premium, deductible, copay and coinsurance explained simply explains the difference.
If your deductible had not been met
Suppose your plan has a $1,000 deductible and you have paid none of it.
- You pay the full allowed price of $500 at the counter, because the plan pays nothing until the deductible is met.
- That $500 counts toward your deductible, usually.
- The plan pays nothing for the claim. The rebate still arrives later and still goes to the plan.
In this case you paid more than the system's net cost for the fill, because you paid the whole counter price, before any rebate. That is one reason some people feel that deductible-phase prices are unfair, and why plans differ in how drug spending counts toward deductibles.
Why the patient's cost and what anyone nets can differ
Four mechanisms in this example create the gap.
- Timing. The rebate arrives months after the claim, so the counter price cannot reflect it.
- Who receives it. The rebate goes to the plan sponsor, which uses it to hold down premiums or plan costs, according to its contract. It does not go to an individual patient.
- The price base. Cost sharing is generally calculated on the allowed price at the counter.
- Confidentiality. Rebate amounts and fee terms are mostly confidential, so a patient cannot see them.
Supporters of the current system say rebates lower premiums and benefit everyone in the plan, since the rebate money offsets the plan's total cost. Critics say the system gives high list prices a role, since a larger rebate on a higher list price can make a drug look attractive to the plan, and that patients who pay coinsurance bear a larger share of the list price than anyone nets. Both statements describe real features of the structure. How much each matters differs across drugs and plans, and the policy proposals are laid out in What PBM reform proposals would change for patients and what critics say.
What a reader can do with this
- Ask your plan's member services whether your drug has a lower-cost alternative, such as a generic or a preferred brand, and where each sits on the drug list.
- Ask whether cost sharing is a copay or coinsurance for the drug, and whether any cap applies.
- Ask your employer's benefits staff, if you have employer coverage, how your plan's benefit manager contract treats rebates. They may not know, but the question is fair.
- Check whether manufacturer coupons count toward your deductible. Under some plans they do not; see copay accumulators and maximizers: why coupons may not count and copay accumulator.
- Ask the pharmacist for the cash price and compare it with your cost after insurance, especially for generics, remembering that cash purchases may not count toward your deductible.
- Ask your prescriber whether another drug fits your condition at a lower cost, a clinical decision that is theirs.
Key takeaways
- In this illustrative $500 fill, you paid $150, the plan paid $237 net after a $115 rebate pass-through, and the $387 total landed as $30 at the pharmacy, $12 at the benefit manager and $345 at the manufacturer.
- Coinsurance is usually calculated on the counter price before any rebate, so your percentage of what anyone nets can be higher than the stated rate.
- Rebates are paid later, to the plan sponsor, and their terms are mostly confidential.
- A copay changes who bears the cost without changing the total.
- Real contracts vary, so treat these numbers as a map of the structure and ask your plan which features apply to you.